Latest News

Print

UCLA Jonsson Comprehensive Cancer Center scientists to present on latest cancer research advancements at AACR 2017

Post Date:March 29, 2017 8:00 AM

Scientists with UCLA’s Jonsson Comprehensive Cancer Center will present some of the most highly anticipated research at the 2017 American Association for Cancer Research (AACR) Annual Meeting. The event takes place at the Walter E. Washington Convention Center in Washington, D.C. from April 1 through April 5.

The AACR Annual Meeting highlights the best in cancer science and medicine, will draw more than 20,000 researchers, clinicians and industry leaders to discuss advances in cancer science.

More than 45 abstracts, sessions and events at AACR 2017 will feature members of UCLA’s Jonsson Comprehensive Cancer Center (JCCC). Below are select symposia, presentations and other events where JCCC researchers are speaking or appearing.

For the complete AACR 2017 Annual Meeting program, please visit their website itinerary.

Major symposia and plenary sessions

Survivorship: Where is the Science Headed?
April 3, 2017, 10:30 a.m.–12:15 p.m.
Room 206, Level 2, Washington Convention Center

  • Patricia A. Ganz, M.D., Director of Prevention and Control Research and Director of the Patients and Survivors Program at JCCC, chairs this session and presents on “Symptom science in cancer survivors: Advances in biology and management”

Update, Novel Indication, and New Immuno-oncology Clinical Trials
April 3, 2017, 3:00 p.m.–5:30 p.m.
Ballroom C, Level 3, Washington Convention Center

  • Antoni Ribas, M.D., Ph.D., Director of the JCCC Tumor Immunology Program and Director of the Parker Institute for Cancer Immunotherapy (PICI) Center at UCLA, will present on “Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients” at 3:20 p.m.

Novel Immuno-oncology Agent Clinical Trials
April 4, 2017, 10:30 a.m.–12:45 p.m.
Ballroom C, Level 3, Washington Convention Center

  • Antoni Ribas, M.D., Ph.D., Director of the JCCC Tumor Immunology Program and Director of the Parker Institute for Cancer Immunotherapy (PICI) Center at UCLA, chairs this session

Advances in Breast Cancer Therapy
April 4, 2017, 10:30 a.m.–12:15 p.m.
Room 202, Level 2, Washington Convention Center

  • Dennis J. Slamon, M.D., Ph.D., Director of JCCC Clinical/Translational Research, presents on “Targeting the Cyclin D:cdk-4/6 pathway in ER+ breast cancer: Opportunities and challenges” at 10:30 a.m.

Role of Interferon Pathway Signaling in Cancer Immunotherapy
April 5, 2017, 10:15 a.m.–12 p.m.
Room 146, Level 1, Washington Convention Center

  • Antoni Ribas, M.D., Ph.D., Director of the JCCC Tumor Immunology Program and Director of the Parker Institute for Cancer Immunotherapy (PICI) Center at UCLA, chairs this session and will present “Resistance to checkpoint blockade through IFN-g pathway alterations” at 11:20 a.m.

Recent Trends in Regulatory Science
April 5, 2017, 10:30 a.m.–12:00 p.m.
Room 143, Level 1, Washington Convention Center

  • Arash Naeim, M.D., Ph.D., JCCC Director of Informatics, presents on “Universal consent for biospecimens: A novel electronic/video consent” at 11:00 a.m.

Educational sessions and workshops

Resistance Mechanisms to MAPK Pathway Targeting Across Cancer
April 1, 2017, 8:00–10:00 a.m.
Room 201, Level 2, Washington Convention Center

  • Roger S. Lo, Ph.D., Director of the Melanoma Clinic in Dermatology at UCLA, chairs this session

Immune Monitoring and Biomarker Development in the Human Model System
April 1, 2017, 10:15 a.m.–12:15 p.m.
Independence Ballroom E-H, Meeting Level 4, Marriott Marquis DC

  • Steven M. Dubinett, M.D., Chief of the Department of Medicine, Pulmonary and Critical Care Medicine at UCLA, chairs this session and presents on “Chemokines and cancer”
  • Robert Prins, Ph.D., associate professor of Neurosurgery and Molecular and Medical Pharmacology at UCLA, presents on “Personalized immunotherapy for glioblastoma”

Awards

Roger S. Lo, Ph.D., Director of the Melanoma Clinic in Dermatology at UCLA will receive the Inaugural AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research during AACR 2017. The Academy is recognizing Lo for his widely recognized his work in understanding treatment-resistant melanoma. Lo will receive his award and present “Therapeutic Resistance in Melanoma” on April 3, 2017, 3:30 p.m.–4:15 p.m., Hall D-E, Level 2, Washington Convention Center.

Return to full list >>